Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Annual change of LCI among patients with cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016
Lung clearance index predicts pulmonary exacerbations in cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Effect of different physiotherapy devices on ventilation distribution in adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Normal lung function in infants with cystic fibrosis shortly after birth Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013
Single-breath washout and association with structural lung changes in children with cystic fibrosis Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease Year: 2016
Lung clearance Index changes over time among patients with cystic fibrosis Source: International Congress 2015 – New findings in paediatric respiratory physiology Year: 2015
Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Cystic fibrosis lung disease assessed by lung clearance index Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Clinical value of lung clearance index (LCI) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis Source: Eur Respir J 2011; 37: 806-812 Year: 2011
Evaluation of the effectiveness of cyclical and constant current on sweat volume and stimulation for cystic fibroses diagnoses Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Two-compartment model of gas mixing in patients with asthma and cystic fibrosis Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013
Lung clearance index in young children with atypical CF Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016
Lung function, weight, and sweat chloride responses in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor: A secondary analysis Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013
Difficulties in optimizing vitamin D levels in paediatric cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014